Efficacy of nonsurgical septal reduction therapy in symptomatic patients with obstructive hypertrophic cardiomyopathy and provocable gradients.
Lakkis
N
N
Section of Cardiology, Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA. nlakkis@bcm.tmc.edu
Plana
J C
JC
Nagueh
S
S
Killip
D
D
Roberts
R
R
Spencer
W H
WH
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006328:Cardiac Catheterization / Q000379:methods; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D004280:Dobutamine; D000431:Ethanol / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006334:Heart Function Tests; D006346:Heart Septum / Q000187:drug effects; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D011336:Probability; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014694:Ventricular Outflow Obstruction / Q000150:complications / Q000175:diagnosis / Q000628:therapy*
D000431:Ethanol; D004280:Dobutamine